Miniso earnings missed by ¥0.26, revenue topped estimates

Miniso (MNSO) reported Q3 EPS of ¥1.88, missing analyst estimates by ¥0.26, while revenue slightly exceeded expectations at ¥4.43B versus the consensus of ¥4.41B. The stock, which closed at ¥22.19, is up 11.01% over the last three months but down 1.42% over the past year, with recent EPS revisions being negative. Despite the EPS miss, InvestingPro assesses Miniso's financial health as demonstrating "great performance."

Analysis

Miniso (MNSO) reported mixed third-quarter results, characterized by an earnings per share (EPS) of ¥1.88, which was ¥0.26 below the analyst consensus of ¥2.14. However, the company's revenue slightly surpassed expectations, reaching ¥4.43 billion compared to the anticipated ¥4.41 billion. This earnings miss is noteworthy, especially considering there has been one negative EPS revision and no positive revisions for Miniso in the last 90 days. Despite the profit shortfall, InvestingPro has assessed Miniso's financial health as demonstrating "great performance." The stock's recent trajectory reflects some investor optimism, with an 11.01% increase over the last three months, although it remains down 1.42% over the past twelve months, closing at ¥22.19. The overall sentiment from the provided signals is mixed (-0.1 sentiment score), indicating a degree of uncertainty surrounding the company's near-term outlook.

Key Decisions for Investors

• Investors should scrutinize the drivers behind the Q3 EPS miss, particularly in light of the slight revenue beat and the reported 'great performance' in financial health, to understand the pressure on profitability.
• Given the recent negative EPS revision and the stock's divergent short-term (up 11.01%) versus long-term (down 1.42%) performance, a cautious approach is warranted until further clarity emerges on sustainable earnings growth.
• Consider monitoring upcoming management commentary and future earnings reports for insights into cost management strategies and efforts to align profitability with revenue generation and overall financial health metrics.